- Phosphoinositide 3-kinase inhibition enables retinoic acid-induced neurogenesis in monolayer culture of embryonic stem cells2012 | Faculty of Medicine in Pilsen
- Disease evolution and response to rapamycin in Activated Phosphoinositide 3-Kinase delta syndrome: the european society for immunodeficiencies-Activated Phosphoinositide 3-Kinase d syndrome registry2018 | Second Faculty of Medicine
- Natural Course of Activated Phosphoinositide 3-Kinase Delta Syndrome in Childhood and Adolescence2021 | Second Faculty of Medicine, First Faculty of Medicine
- Inhibitors of phosphoinositide 3-kinase (PI3K) and phosphoinositide 3-kinase-related protein kinase family (PIKK)2023 | Publication without faculty affiliation
- Clinical spectrum and features of activated phosphoinositide 3-kinase delta syndrome: A large patient cohort study2017 | Second Faculty of Medicine
- Occurrence of B-cell lymphomas in patients with activated phosphoinositide 3-kinase delta syndrome2014 | Second Faculty of Medicine
- Interleukin-22 promotes the proliferation and migration of hepatocellular carcinoma cells via the phosphoinositide 3-kinase (PI3K/AKT) signaling pathway2023 | Faculty of Medicine in Pilsen
- Activated Phosphoinositide 3-Kinase δ Syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity2023 | Second Faculty of Medicine
- Effective "activated PI3K delta syndrome"-targeted therapy with the PI3Kd inhibitor leniolisib2017 | Second Faculty of Medicine
- The peripheral cannabinoid receptor Cb2, a novel oncoprotein, induces a reversible block in neutrophilic differentiation2003 | Central Library of Charles University
- Novel caffeine derivatives with antiproliferative activity2016 | Faculty of Medicine in Hradec Králové
- Diseases of the gastrointestinal tract in patients with primary immunodeficiency2017 | Faculty of Medicine in Hradec Králové
- The interaction of p130Cas with PKN3 promotes malignant growth2019 | Faculty of Science
- A Role of PI3K/Akt Signaling in Oocyte Maturation and Early Embryo Development2023 | Faculty of Science
- Contemporary mTOR inhibitor scaffolds to diseases breakdown: A patent review (2015-2021)2022 | Publication without faculty affiliation
- COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group2023 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Radio-sensitization of human leukaemic MOLT-4 cells by DNA-dependent protein kinase inhibitor, NU70262012 | Faculty of Medicine in Hradec Králové
- Molecular and Cellular Mechanisms Associated with Effects of Molecular Hydrogen in Cardiovascular and Central Nervous Systems2020 | First Faculty of Medicine
- Buparlisib is a novel inhibitor of daunorubicin reduction mediated by aldo-keto reductase 1C32019 | Faculty of Pharmacy in Hradec Králové
- mTOR inhibition amplifies the anti-lymphoma effect of PI3Kβ/δ blockage in diffuse large B-cell lymphoma2023 | First Faculty of Medicine, Third Faculty of Medicine
- Autosomal Dominant Polycystic Kidney Disease: From Pathophysiology of Cystogenesis to Advances in the Treatment2022 | First Faculty of Medicine
- Randomized, Placebo-Controlled, Phase 3 Trial of PI3Kδ Inhibitor Leniolisib for Activated PI3Kδ Syndrome2023 | Second Faculty of Medicine
- Interim Analysis: Open-Label Extension Study of Leniolisib for Patients with APDS2024 | Second Faculty of Medicine